Clinical Trial Detail

NCT ID NCT03516708
Title Epacadostat (INCB024360) and Pembrolizumab Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

rectum cancer

Therapies

Pembrolizumab

Epacadostat

Capecitabine + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.